Medicare Compliance & Reimbursement - 2014 Issue 41
Reader Question: Know How to Report Single Blepharospasm Injection
Subscribe or sign in to view the full article.
Article Overview
This reader Q&A addresses reporting of a Botox treatment for blepharospasm when treatment is limited to one eye, and it also touches on bilateral reporting, diagnosis linkage, and drug supply billing. It is useful for ophthalmology practices, medical coders, and billing staff who need a high-level understanding of the coding topics covered in the article.
Why This Topic Matters
Questions about unilateral versus bilateral treatment, diagnosis linkage, and drug supply reporting are common in ophthalmology billing. Understanding the scope of this article helps readers quickly determine whether they need the full premium guidance for their specific billing scenario.
What You Will Learn
- How the article frames billing for a blepharospasm injection treatment scenario
- What general coding topics are discussed for a single-eye versus both-eye treatment context
- How the article connects procedure coding, diagnosis coding, and drug supply billing at a high level
- What documentation and payer-policy themes are mentioned in relation to the service
Who Should Read This
- Medical coders
- Billing staff
- Ophthalmology practices
- Revenue cycle professionals
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com